However, in mice fed on obesity-inducing diet, the Kv1.3 blocker ShK-186 reduced body weight and adiposity by increasing energy expenditure upon activation of the brown adipose tissue, but not the white, and by reducing the inflammation of abdominal fat [14]. Here, KCNA3 is linked to obesity disorder.